Latest Equity Issuance News

Apiam Animal Health has secured court approval for its corporate scheme, paving the way for a fully franked special dividend payment next month.

Small caps did the heavy lifting this week, led by two big discovery stories in resources. Funding raises and takeover moves kept attention on who can pay for the next step, not just promise it.

Speculative money piled into new discoveries and tight-supply metals, while a handful of small caps were sold hard on thin liquidity. The week’s biggest moves came from PGMs and tungsten on the way up, and micro-cap gas on the way down.

Bowen Coking Coal Limited has reported a challenging quarter ending December 2025, marked by cash outflows, a default on its senior secured debt, and ongoing voluntary administration.

Challenger Gold Limited reported a challenging quarter ending December 2025, with significant cash outflows from operations and investing activities, yet maintains a strong cash position supported by a convertible debenture facility.

North Stawell Minerals Ltd reported a solid cash position of AUD 1.6 million at the end of December 2025, supporting just over two quarters of funding as it advances its exploration program. The company plans additional capital raises to sustain operations through 2026.

European Lithium Limited has bolstered its cash reserves with over A$300 million from share sales in Critical Metals Corp, while delivering promising high-grade rare earth drilling results at its Greenland Tanbreez Project.

5E Advanced Materials has filed a Post-Effective Amendment to its SEC registration, updating the legal opinion on its planned issuance of up to 18 million shares. This move clears a key regulatory step in the company’s capital raising journey.

5E Advanced Materials has filed an SEC amendment to increase its public offering by $6 million, signalling a strategic move to bolster its capital base.

Skin Elements Limited has marked a pivotal quarter with a $2.5 million capital raise and successful product evaluations, setting the stage for commercial rollout of its natural biotechnology range in 2026.

Diablo Resources reported a net cash outflow of A$456k for operating activities in the December 2025 quarter, offset partially by a A$2 million equity raise. Despite this, the company’s cash runway remains limited to about one quarter, prompting plans for further funding.

E79 Gold Mines Limited reported a solid quarter with a $3.1 million equity raise, ending December 2025 with $3.58 million in cash despite ongoing operating losses.